Collaborations
Scientific Collaborations
– Dr Howard Chertkow : Website
– Dr Frédéric Calon : Website
– Dr Thanh Dang-Vu : Website
– Dr Jamie Near : Website
– Dre Lisa Munter : Website
– Dr Jens C Pruessner : Website
– Dr Claudio Cuello : Website
– Dr Daniel Auld : Website
– Dr Alain Dagher : Website
– Dr Robert Zatorre : Website
– Dr Danilo Bzdok : Website
– Dr Bratislav Misic : Website
– Dr Jean-Baptiste Poline : Website
– Dr Boris Bernhardt : Website
– Dr Paolo Vitali : Website
– Dr Alan Barkun : Website
– Dre Véronique Latreille : Website
– Dre Nathalie Arbour : Website
– Dr Benoit Jutras : Website
– Dr Louis de Beaumont : Website
– Dr Maxime Descoteaux : Website
– Dr Jean-François Gagnon : Website
– Dr Andrew Lim : Website
– Dre Rebecca Robillard : Website
– Dr Gary Turner : Website
– Dr Sterling C Johnson : Website
– Dre Nathalie Marchand : Website
– Dr Art Kramer : Website
– Dr David G Morgan : Website
– Dre Reisa Sperling : Website
-Dr Aaron Alexander Bloch : Website
– Dr Renaud Lajoie : Website
– Dr Michael Weiner : Website
– Dr Bryce Mander : Website
– Dr Terrence Town : Website
– Dr Timothy Hohman : Website
– Dre Michelle Miekle : Website
– Dr Christopher Chen : Website
– Dr Rik Ossenkoppele : Website
– Dr Philip Scheltens : Website
– Dr Anne Maass : Website
– Dr Henrik Zetterberg : Website
– Dr Michael Ewers : Website
– Dr Jean-Charles Lambert : Website
– Dr Philippe Amouyei : Website
– Dr Tormod Fladby : Website
– Dr Kaj Blennow : Website
– Dr Nicholas Ashton : Website
– Dre Ann Brinkmlam : Website
– Dr Oskar Hansson : Website
– Dr Alberto Lleo : Website
Private Collaborations
Optina Diagnostics
Participants from the PREVENT-AD cohort took part in the study that led to the development of the Retinal Deep Phenotyping™, a platform that shows promise for detecting probable brain amyloid PET status in adults 50 years and older from a simple, non-invasive retinal exam and could provide an accessible means of identifying individuals with abnormal brain amyloid in a clinical or drug development context.